Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | REGN | ALNY | ||
| Company | Argenx Se ADR | Regeneron Pharmaceuticals | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 786.71 | 751.37 | 308.97 | ||
| High | 788.52 | 754.00 | 314.17 | ||
| Low | 766.93 | 734.80 | 302.34 | ||
| Latest | 770.72 | 734.04 | 302.60 | ||
| Change | -13.02 | -10.40 | -5.91 | ||
| % Change | -1.66% | -1.40% | -1.92% | ||
| Volume | 127,978 | 250,216 | 400,748 | ||
| 20-Day Average Volume | 290,629 | 646,734 | 1,009,719 | ||
| Previous Close | 783.74 | 744.44 | 308.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 791.43 | 756.12 | 319.84 | ||
| 20-Day Raw Stochastic | 42.25% | 6.46% | 7.00% | ||
| 20-Day Relative Strength | 48.18 | 44.70 | 42.27 | ||
| Weighted Alpha | +14.96 | +23.78 | -3.19 | ||
| Today's Opinion | 24% Sell | 8% Buy | 100% Sell | ||
| Previous Opinion | 8% Sell | 16% Buy | 100% Sell | ||
| Last Month's Opinion | 72% Sell | 24% Buy | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.52% since 04/21/26 | -1.36% since 04/21/26 | -1.26% since 04/21/26 | ||
| Low | 768.02 on 04/28/26 | 734.79 on 04/28/26 | 302.89 on 04/24/26 | ||
| High | 805.74 on 04/22/26 | 767.21 on 04/23/26 | 315.83 on 04/23/26 | ||
| 1-Month | |||||
| %Chg | +11.23% since 03/27/26 | -0.07% since 03/27/26 | -4.04% since 03/27/26 | ||
| Low | 693.56 on 03/30/26 | 734.12 on 04/21/26 | 301.63 on 04/21/26 | ||
| High | 852.28 on 04/17/26 | 781.21 on 04/01/26 | 343.36 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | -9.18% since 01/28/26 | -1.86% since 01/28/26 | -12.88% since 01/28/26 | ||
| Low | 661.85 on 03/20/26 | 727.88 on 03/19/26 | 298.00 on 02/12/26 | ||
| High | 861.72 on 02/05/26 | 815.00 on 02/17/26 | 355.49 on 02/04/26 | ||
| 6-Month | |||||
| %Chg | -8.06% since 10/28/25 | +12.63% since 10/28/25 | -36.01% since 10/28/25 | ||
| Low | 661.85 on 03/20/26 | 625.14 on 11/04/25 | 298.00 on 02/12/26 | ||
| High | 934.62 on 12/03/25 | 821.11 on 01/09/26 | 482.73 on 10/29/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 48,739,216 | 78,702,200 | 41,163,872 | ||
| Shares Outstanding, K | 62,188 | 105,720 | 133,428 | ||
| Annual Sales | 4,248,050,000 | 14,342,900,000 | 3,713,940,000 | ||
| Annual Net Income | 1,292,040,000 | 4,504,900,000 | 313,750,000 | ||
| Last Quarter Sales | 1,322,160,000 | 3,884,300,000 | 1,097,030,000 | ||
| Last Quarter Net Income | 532,950,000 | 844,600,000 | 186,420,000 | ||
| 60-Month Beta | 0.46 | 0.40 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 8.02 on 02/26/26 | 11.44 on 01/30/26 | 1.25 on 02/12/26 | ||
| Earnings Date | 05/14/26 | 04/29/26 | 04/30/26 | ||
| Most Recent Dividend | N/A | 0.940 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 39.97 | 20.83 | 179.73 | ||